Complete pathological response following neoadjuvant FOLFIRINOX in borderline resectable pancreatic cancer - a case report and review
- Publisher: BioMed Central
(issn: 1471-2407, eissn: 1471-2407)
Complete pathological response | Borderline resectable | Pancreatic cancer | Genetics | FOLFIRINOX | Case report | Neoadjuvant therapy | Cancer Research | Oncology | Locally-advanced
Background Pancreatic cancer is among the top 5 most common cancers worldwide, but is particularly devastating due to its insidious nature. Complete surgical resection remains the only potential curative treatment, although only 20 % of patients present with a resectabl...